Use of antiretroviral therapy in resource-limited countries in 2006: Distribution and uptake of first- and second-line regimens

AIDS

Volumn 21, Issue SUPPL. 4, 2007, Pages

  Renaud Théry, Françoise ^a   Nguimfack, Boniface Dongmo ^a   Vitoria, Marco ^a   Lee, Evan ^b   Graaff, Peter ^a   Samb, Badara ^a   Perriëns, Joseph ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NONE

Author keywords

Active pharmaceutical ingredients: production; Anti HIV agents: supply distribution therapeutic use; Antiretroviral therapy: uptake demand forecasting; Resource limited countries: economics

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR PLUS RITONAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR PLUS SAQUINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEVELOPING COUNTRY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL ANALYSIS; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DEVELOPING COUNTRIES; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; MEDICALLY UNDERSERVED AREA; PATIENT COMPLIANCE; PRACTICE GUIDELINES; WORLD HEALTH ORGANIZATION;

EID: 34447342574     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000279711.54922.f0     Document Type: Article

References (11)

1. Galarraga O, O'Brien M, Gutiérrez J, Renaud-Thery F, Dongmo-Nguimfack B, Waldman K, et al. Forecast of demand for ARV drugs in low- and middle-income countries, 2007-2008. AIDS 2007; 21:00-00.
2. World Health Organization. Scaling up antiretroviral therapy: treatment guidelines for a public health approach. Geneva, Switzerland: World Health Organization; 2004.
3. World Health Organization, Department of HIV/AIDS. Global price reporting mechanism. Geneva, Switzerland: World Health Organization; 2005. Available at: http://www.who.int/hiv/amds/gprm/en/index.html. Accessed: 10 February 2007.
4. Joint United Nations Programme on HIV/AIDS and World Health Organization. Q&A on HIV/AIDS estimates: understanding the latest estimates of the 2006 report on the global AIDS epidemic. Geneva, Switzerland: World Health Organization; 2006.
5. World Health Organization. Towards universal access by 2010: how WHO is working with countries to scale-up HIV prevention, treatment, care and support. Geneva, Switzerland: World Health Organization; 2006.
6. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2006.
7. AIDS Medicines and Diagnostics Service of the World Health Organization. Sources and prices of active pharmaceutical ingredients. Geneva, Switzerland World Health Organization; 2007. 10 March 2007. Available at: http://ftp.who.int/htm/AMDS/sourcespricesAPI.pdf.
8. World Health Organization. Taking stock: HIV in children. Geneva, Switzerland: World Health Organization; 2006.
9. Clinton Foundation. President Clinton announces breakthroughs in HIV/AIDS treatment for children - 3-in-1 pill for less than $60 annually and 45% price reductions for other pediatric drugs. Quincy, Massachusetts: Clinton Foundation; 2006. Available at: http://www.clintonfoundation.org/113006-nr-cf- hs-ai-ind-prwjc-announces-breakthroughs-in-hiv-aids-treatment-for-children.htm. Accessed: 2 December 2006.
10. Medeiros R, Diaz RS, Filho AC. Estimating the length of the first antiretorival therapy regimen durability in Sao Paulo, Brazil. Braz J Infect Dis 2002; 6:298-304.
11. Medical Research Council Clinical Trials Unit. Development of antiretroviral therapy in Africa. Available at: http://www.ctu.mrc.ac.uk/ dart/default.asp. Accessed: 28 February 2007.